IP Library Granted Patent US 12,296,182
Granted Patent B2
US 12,296,182 · App. 18/540,437 · Granted May 13, 2025

Minimally invasive leadless neurostimulation device

Inventors: Steven Deininger (Plymouth, MN); Alan Shi (Plymouth, MN); Thomas M. Hillebrand (Minneapolis, MN)
Assignee: Medtronic, Inc.
A61N1/3756A61N1/0551
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,296,182
App. No.
18/540,437
Granted
May 13, 2025
Kind
B2
Abstract

A leadless neurostimulation device including a header unit having at least one primary electrode having a contact surface that defines an external surface on a side of the device, an outer housing that forms a side of the header unit opposite of the contact surface of the primary electrode, and a dielectric mount that receives at least a portion of the primary electrode and at least partially surrounds the primary electrode, the dielectric mount being configured to electrically insulate the primary electrode from the outer housing, the dielectric mount being received and fixed within a recessed portion of the outer housing, and a housing having a secondary electrode positioned on the same side of the leadless neurostimulation device as the primary electrode, the primary electrode and the secondary electrode being configured to transmit an electrical stimulation signal therebetween to provide electrical stimulation therapy to a tibial nerve of a patient.

Claims (28)

1. A leadless neurostimulation device comprising:

a header unit comprising:

a primary electrode;

an outer housing; and

a dielectric mount that receives at least a portion of the primary electrode and at least partially surrounds the primary electrode, the dielectric mount being configured to electrically insulate the primary electrode from the outer housing, the dielectric mount being received and fixed within a recessed portion of the outer housing; and

a housing comprising a secondary electrode, wherein the primary electrode and the secondary electrode are configured to transmit an electrical stimulation signal therebetween to provide electrical stimulation therapy to a tibial nerve of a patient.

2. The leadless neurostimulation device of claim 1 , wherein the primary electrode comprises an interior surface that defines an interlocking structure with the dielectric mount.

3. The leadless neurostimulation device of claim 1 , further comprising a lead pin configured to pass through a mounting plate and connect to processing circuitry and components contained in the housing that are configured to transmit the electrical stimulation signal between the primary electrode or the secondary electrode to provide electrical stimulation therapy to the tibial nerve, wherein the primary electrode is electrically coupled to the lead pin.

4. The leadless neurostimulation device of claim 3 , wherein the primary electrode comprises Grade 2 titanium, a titanium alloy, or a Platinum-Iridium alloy, and wherein the lead pin comprises niobium.

5. The leadless neurostimulation device of claim 1 , wherein the dielectric mount defines a channel between the outer housing and the dielectric mount, the channel configured to receive a medical adhesive deposited therein to fix the outer housing to the dielectric mount.

6. The leadless neurostimulation device of claim 5 , wherein the outer housing defines a filling port in fluid communication with the channel to allow injection of the medical adhesive into the channel.

7. The leadless neurostimulation device of claim 1 , wherein the primary electrode has a contact surface that defines an external surface on a side of the leadless neurostimulation device, the contact surface being about 15 mm 2 to about 35 mm 2 .

8. The leadless neurostimulation device of claim 1 , wherein the secondary electrode is positioned on the same side of the leadless neurostimulation device as the at least one primary electrode.

9. The leadless neurostimulation device of claim 1 , wherein the primary electrode and the secondary electrode define a separation distance of about 10 mm to about 20 mm.

10. The leadless neurostimulation device of claim 1 , wherein the secondary electrode defines a contact surface area of about 40 mm 2 to about 120 mm 2 .

11. The leadless neurostimulation device of claim 1 , further comprising a dielectric coating that at least partially encapsulates the leadless neurostimulation device.

12. The leadless neurostimulation device claim 11 , wherein a boundary defined by the dielectric coating defines the secondary electrode.

13. The leadless neurostimulation device of claim 1 , wherein the device defines a total volume of about 1.5 cubic centimeters (cc) to about 3.5 cc.

14. The leadless neurostimulation device of claim 1 , further comprising a mounting plate, wherein the housing is coupled to a first side of the mounting plate and the header unit is coupled to a second side of the mounting plate.

15. A header unit for an implantable electrical stimulation device comprising:

a primary electrode;

an outer housing; and

a dielectric mount that receives at least a portion of the primary electrode and at least partially surrounds the primary electrode, the dielectric mount being configured to electrically insulate the primary electrode from the outer housing, the dielectric mount being received and fixed within a recessed portion of the outer housing.

16. The header unit of claim 15 , wherein the primary electrode defines a substantially flat surface configured to contact patient tissue.

17. The header unit of claim 15 , wherein the primary electrode defines a partially curved surface configured to contact patient tissue.

18. The header unit of claim 15 , wherein the primary electrode defines a contact surface protruding from a plane defined by the outer housing, the contact surface configured to provide pressure against patient tissue to enhance electrical stimulation strength of the primary electrode.

19. The header unit of claim 15 , wherein the outer housing defines a perimeter edge that provides a substantially smooth surface without sharp edges to prevent patient irritation upon implantation of the header unit.

20. The header unit of claim 15 , wherein the outer housing is configured to receive and form a partial shell around the dielectric mount.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 14, 2023
From: DEININGER, STEVEN; SHI, ALAN; HILLEBRAND, THOMAS M.
To: MEDTRONIC, INC.
Reel/Frame 065875/0742 →
Continuity (3)
Continuation 17485292 · Sep 24, 2021
Provisional Application 63198053 · Sep 25, 2020
Related Publication 20240108905A1 · Apr 4, 2024
References Cited (64)
US D337820S · Hooper et al. · 1993 [cited by applicant]
US D350206S · Mochida · 1994 [cited by applicant]
US 5987352A · Klein et al. · 1999 [cited by applicant]
US 6230059B1 · Duffin · 2001 [cited by applicant]
US 6522915B1 · Ceballos et al. · 2003 [cited by applicant]
US 6735474B1 · Loeb et al. · 2004 [cited by applicant]
US D523557S · Jones et al. · 2006 [cited by applicant]
US 7894907B2 · Cowan et al. · 2011 [cited by applicant]
US 8831747B1 · Min et al. · 2014 [cited by applicant]
US 9220911B2 · Gordon et al. · 2015 [cited by applicant]
US 9351648B2 · Mothilal et al. · 2016 [cited by applicant]
US 9433786B2 · Greiner et al. · 2016 [cited by applicant]
US 9511236B2 · Varady et al. · 2016 [cited by applicant]
US 9555246B2 · Jiang et al. · 2017 [cited by applicant]
US 9597518B2 · Deininger et al. · 2017 [cited by applicant]
US 10238880B2 · Thom et al. · 2019 [cited by applicant]
US 10328273B2 · Hovland et al. · 2019 [cited by applicant]
US D862716S · Cryan et al. · 2019 [cited by applicant]
US 10478612B2 · Schepis et al. · 2019 [cited by applicant]
US D893729S · Joda et al. · 2020 [cited by applicant]
US D893736S · Yin · 2020 [cited by applicant]
US D899610S · Yang · 2020 [cited by applicant]
US D907222S · Xu · 2021 [cited by applicant]
US D908901S · Chen · 2021 [cited by applicant]
US D923803S · Ito et al. · 2021 [cited by applicant]
US 11045650B2 · Brink et al. · 2021 [cited by applicant]
US D952852S · Deininger et al. · 2022 [cited by applicant]
US D952853S · Clayton et al. · 2022 [cited by applicant]
US 11878179B2 · Deininger · 2024 [cited by examiner]
US 20050288600A1 · Zhang et al. · 2005 [cited by applicant]
US 20070049975A1 · Cates et al. · 2007 [cited by applicant]
US 20080004535A1 · Smits · 2008 [cited by applicant]
US 20080119903A1 · Arcot-Krishnamurthy · 2008 [cited by applicant]
US 20080195165A1 · Stahmann et al. · 2008 [cited by applicant]
US 20080243200A1 · Scinicariello et al. · 2008 [cited by applicant]
US 20090082828A1 · Ostroff · 2009 [cited by applicant]
US 20110301670A1 · Gross et al. · 2011 [cited by applicant]
US 20120101326A1 · Simon et al. · 2012 [cited by applicant]
US 20120197337A1 · Su et al. · 2012 [cited by applicant]
US 20140043739A1 · Deininger et al. · 2014 [cited by applicant]
US 20140163579A1 · Tischendorf et al. · 2014 [cited by applicant]
US 20140344740A1 · Kaula et al. · 2014 [cited by applicant]
US 20170157405A1 · Deininger et al. · 2017 [cited by applicant]
US 20170224584A1 · Greiner et al. · 2017 [cited by applicant]
US 20170296426A1 · Oron et al. · 2017 [cited by applicant]
US 20190314635A1 · Iyer et al. · 2019 [cited by applicant]
US 20220096845A1 · Deininger et al. · 2022 [cited by applicant]
US 20220096846A1 · Deininger et al. · 2022 [cited by applicant]
CN 104797291A · 2015 [cited by applicant]
CN 104812438 · 2015 [cited by applicant]
CN 105492069A · 2016 [cited by applicant]
CN 107106841A · 2017 [cited by applicant]
CN 109069825A · 2018 [cited by applicant]
CN 110062643A · 2019 [cited by applicant]
CN 111447969A · 2020 [cited by applicant]
WO 2014153219A1 · 2014 [cited by applicant]
Search report from related Chinese Application CN 202180070020.4, dated Jul. 26, 2023, 9 pgs. No english translation available. [cited by applicant]
Search report from related Chinese Application CN 202180071032.9, dated Aug. 9, 2023, 10 pgs. No english translation available. [cited by applicant]
International Preliminary Report on Patentability from related PCT Application PCT/US2021/052094, dated Mar. 28, 2023, 7 pgs. [cited by applicant]
International Search Report and Written Opinion from PCT Application PCT/US2021/052094, dated Jan. 21, 2022, 9 pgs. [cited by applicant]
Application and file history for U.S. Appl. No. 29/652,586, filed Sep. 25, 2020, inventors Deininger et al. [cited by applicant]
Application and file history for U.S. Appl. No. 29/652,587, filed Sep. 25, 2020, inventors Deininger et al. [cited by applicant]
Application and file history for U.S. Appl. No. 17/485,303, filed Sep. 24, 2021, inventors Deininger et al. [cited by applicant]
Application and file history for U.S. Appl. No. 17/485,292, filed SEotenber 24, 2021, inventors Deininger et al. [cited by applicant]